Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Behrens

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|April 11, 2025
Interoccasion variability in population pharmacokinetic models: identifiability, influence, interdependencies and derived study design recommendationsEmily Behrens, Sebastian G Wicha
SAGE Open Medical Case Reports|May 9, 2019
Rowell syndrome with recurrence from photoexacerbation: A case reportSuzanne Alkul, Emily Behrens, Cloyce Stetson
Dermatology Online Journal|April 11, 2018
Circumscribed palmar hypokeratosisNerissa C D'Silva, Emily Behrens, Ashley Sturgeon, et al.
Dermatology Online Journal|November 19, 2019
Classic features of primary systemic amyloidosis (AL amyloidosis) leading to diagnosis of plasma cell myelomaKendra W Tan, Brian Zhu, Emily Behrens, et al.
Proceedings (Baylor University. Medical Center)|October 29, 2019
Contrast-induced generalized bullous fixed drug eruption resembling Stevens-Johnson syndromeMeredith Gavin, Leigha Sharp, Kendra Walker, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2025
Towards precision dosing of vancomycin in patients with allogeneic hematopoietic stem cell transplantation: a comparison of published population pharmacokinetic modelsEva-Maria A Wansing, Emily Behrens, Nicolaus M Kröger, et al.
Annals of Intensive Care|May 29, 2026
Prospective study of pharmacokinetics of isavuconazole in critically ill patients undergoing continuous hemodialysis with and without acute-on-chronic liver failureEmily Behrens, Christina König, Dominik Jarczak, et al.
Tuberculosis (Edinburgh, Scotland)|February 13, 2026
Towards model-informed precision dosing of clofazimine, moxifloxacin, and terizidone/cycloserine in the treatment of drug-resistant tuberculosis: An external model evaluation studyEmily Behrens, Niklas Köhler, Max Münchow, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Pharmacokinetics and Pharmacodynamics|April 11, 2025
Interoccasion variability in population pharmacokinetic models: identifiability, influence, interdependencies and derived study design recommendationsEmily Behrens, Sebastian G Wicha
SAGE Open Medical Case Reports|May 9, 2019
Rowell syndrome with recurrence from photoexacerbation: A case reportSuzanne Alkul, Emily Behrens, Cloyce Stetson
Dermatology Online Journal|April 11, 2018
Circumscribed palmar hypokeratosisNerissa C D'Silva, Emily Behrens, Ashley Sturgeon, et al.
Dermatology Online Journal|November 19, 2019
Classic features of primary systemic amyloidosis (AL amyloidosis) leading to diagnosis of plasma cell myelomaKendra W Tan, Brian Zhu, Emily Behrens, et al.
Proceedings (Baylor University. Medical Center)|October 29, 2019
Contrast-induced generalized bullous fixed drug eruption resembling Stevens-Johnson syndromeMeredith Gavin, Leigha Sharp, Kendra Walker, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2025
Towards precision dosing of vancomycin in patients with allogeneic hematopoietic stem cell transplantation: a comparison of published population pharmacokinetic modelsEva-Maria A Wansing, Emily Behrens, Nicolaus M Kröger, et al.
Annals of Intensive Care|May 29, 2026
Prospective study of pharmacokinetics of isavuconazole in critically ill patients undergoing continuous hemodialysis with and without acute-on-chronic liver failureEmily Behrens, Christina König, Dominik Jarczak, et al.
Tuberculosis (Edinburgh, Scotland)|February 13, 2026
Towards model-informed precision dosing of clofazimine, moxifloxacin, and terizidone/cycloserine in the treatment of drug-resistant tuberculosis: An external model evaluation studyEmily Behrens, Niklas Köhler, Max Münchow, et al.
Pageof 1